Stay updated on Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page indicates a ClinicalTrials.gov software/content release update, changing the displayed site revision from v3.5.2 to v3.5.3 without any corresponding updates to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:10.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Version bump from v3.5.0 to v3.5.2. No user-facing content or functionality changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:50.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:29:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this appears to be a version label rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-03-12T02:25:16.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page adds a revision tag 'Revision: v3.4.2' and removes a government funding notice that was previously shown. These changes affect only site-wide information and do not alter the study details, eligibility criteria, outcomes, or contacts.
    Difference
    0.5%
    Check dated 2026-02-11T14:34:41.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A funding-lapse notice was added at the top of the page and the revision tag updated to v3.4.1, replacing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:39:08.000Z thumbnail image

Stay in the know with updates to Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page.